Shalini Sharp Insider Trading $RARE Ultragenyx Pharmaceutical Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Shalini Sharp.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Shalini Sharp. Shalini Sharp is Director in NEUROCRINE BIOSCIENCES INC ($NBIX) and CFO in AGENUS INC ($AGEN) and Director in AGENUS INC ($AGEN) and in ARRAY BIOPHARMA INC ($ARRY) and Director in ARRAY BIOPHARMA INC ($ARRY) and Director in SUTRO BIOPHARMA, INC. ($STRO) and CFO & Executive Vice President in Ultragenyx Pharmaceutical Inc. ($RARE) and CFO & Senior Vice President in Ultragenyx Pharmaceutical Inc. ($RARE) and EVP, Finance in Ultragenyx Pharmaceutical Inc. ($RARE) and in Mirati Therapeutics, Inc. ($MYG) and Director in Nuvation Bio Inc. ($PANA) and Director in Organon & Co. ($OGN).

Shalini Sharp in Ultragenyx Pharmaceutical Inc.

Trading Symbol: RARE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Shalini Sharp: EVP, Finance, CFO & Executive Vice President, CFO & Senior Vice President
Holdings: 97,812 shares
Current Value: $7,131,473
Latest Transaction: Oct 16 2020
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Shalini Sharp in Ultragenyx Pharmaceutical Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AGEN, ARRY, MYG, NBIX, NUVB, OGN, STRO, RARE

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Oct 16 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	EVP, Finance	Sell	S	87.99	375	32,996	97,812	98.2 K to 97.8 K (-0.38 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	48.43	3,669	177,690	15,312
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	67.55	7,188	485,549	15,812
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	70.57	500	35,285	0
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	88.38	3,669	324,266	98,187	101.9 K to 98.2 K (-3.60 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	48.43	3,669	177,690	101,856	98.2 K to 101.9 K (+3.74 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	88.38	7,188	635,275	98,187	105.4 K to 98.2 K (-6.82 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	67.55	7,188	485,549	105,375	98.2 K to 105.4 K (+7.32 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	88.38	500	44,190	98,187	98.7 K to 98.2 K (-0.51 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	70.57	500	35,285	98,687	98.2 K to 98.7 K (+0.51 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	88.54	2,560	226,662	98,187	100.7 K to 98.2 K (-2.54 %)
Aug 19 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	88.24	461	40,679	100,747	101.2 K to 100.7 K (-0.46 %)
Jun 05 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	48.43	2,564	124,175	18,981
Jun 05 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	48.43	10,234	495,633	21,545
Jun 05 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	74.01	2,564	189,762	101,208	103.8 K to 101.2 K (-2.47 %)
Jun 05 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	48.43	2,564	124,175	103,772	101.2 K to 103.8 K (+2.53 %)
Jun 05 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	74.23	10,234	759,670	101,208	111.4 K to 101.2 K (-9.18 %)
Jun 05 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	48.43	10,234	495,633	111,442	101.2 K to 111.4 K (+10.11 %)
Jun 03 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	69.38	348	24,144	101,208	101.6 K to 101.2 K (-0.34 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	70.57	3,907	275,717	500
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	48.43	3,221	155,993	31,779
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	70.57	19,593	1,382,678	4,407
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	73.32	3,907	286,461	101,556	105.5 K to 101.6 K (-3.70 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	70.57	3,907	275,717	104,851	100.9 K to 104.9 K (+3.87 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	73.32	3,221	236,164	100,944	104.2 K to 100.9 K (-3.09 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	48.43	3,221	155,993	104,165	100.9 K to 104.2 K (+3.19 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	73.29	2,392	175,310	100,944	103.3 K to 100.9 K (-2.31 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	73.34	19,593	1,436,951	103,336	122.9 K to 103.3 K (-15.94 %)
May 20 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	70.57	19,593	1,382,678	122,929	103.3 K to 122.9 K (+18.96 %)
May 08 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	66.26	248	16,432	103,336	103.6 K to 103.3 K (-0.24 %)
Apr 21 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	58.57	248	14,525	103,584	103.8 K to 103.6 K (-0.24 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	56.08	2,325	130,386	103,832	106.2 K to 103.8 K (-2.19 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Grant	A	0.00	5,634	0	106,157	100.5 K to 106.2 K (+5.60 %)
Oct 16 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Grant	A	0.00	1,434	0	100,523	99.1 K to 100.5 K (+1.45 %)
Sep 17 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	6.86	24,880	170,677	2,998
Sep 17 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	0.81	6,963	5,640	0
Sep 17 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	6.86	24,880	170,677	99,089	74.2 K to 99.1 K (+33.53 %)
Sep 17 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	0.81	6,963	5,640	74,209	67.2 K to 74.2 K (+10.35 %)
Jun 04 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	54.93	346	19,006	67,246	67.6 K to 67.2 K (-0.51 %)
May 22 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	59.50	381	22,670	67,592	68 K to 67.6 K (-0.56 %)
May 07 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Grant	A	0.00	1,434	0	67,973	66.5 K to 68 K (+2.16 %)
Apr 23 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	64.43	248	15,979	66,078	66.3 K to 66.1 K (-0.37 %)
Mar 20 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	6.86	12,000	82,320	27,878
Mar 20 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	70.00	14,800	1,036,000	66,357	81.2 K to 66.4 K (-18.24 %)
Mar 20 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	6.86	12,000	82,320	81,157	69.2 K to 81.2 K (+17.35 %)
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	A	67.55	23,000	1,553,650	23,000
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	67.55	981	66,267	69,156	70.1 K to 69.2 K (-1.40 %)
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Grant	A	0.00	8,000	0	70,137	62.1 K to 70.1 K (+12.87 %)
Oct 31 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	0.82	12,000	9,780	6,963
Oct 31 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	0.82	12,000	9,780	62,128	50.1 K to 62.1 K (+23.94 %)
Sep 27 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	0.82	3,350	2,730	18,963
Sep 27 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	90.07	6,700	603,469	50,128	56.8 K to 50.1 K (-11.79 %)
Sep 27 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	0.82	3,350	2,730	56,828	53.5 K to 56.8 K (+6.26 %)
Jun 07 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	0.82	3,350	2,730	22,313
Jun 07 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	80.07	6,700	536,456	53,478	60.2 K to 53.5 K (-11.13 %)
Jun 07 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	0.82	3,350	2,730	60,178	56.8 K to 60.2 K (+5.89 %)
Jun 04 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	73.73	346	25,511	56,828	57.2 K to 56.8 K (-0.61 %)
May 30 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	0.82	6,500	5,298	25,663
May 30 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	70.17	13,000	912,171	57,174	70.2 K to 57.2 K (-18.53 %)
May 30 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	0.82	6,500	5,298	70,174	63.7 K to 70.2 K (+10.21 %)
May 22 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	64.79	381	24,685	63,674	64.1 K to 63.7 K (-0.59 %)
Apr 19 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Grant	A	0.00	1,431	0	63,544	62.1 K to 63.5 K (+2.30 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	A	48.43	35,000	1,695,050	35,000
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	48.43	397	19,227	62,113	62.5 K to 62.1 K (-0.64 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Grant	A	0.00	7,000	0	62,510	55.5 K to 62.5 K (+12.61 %)
Jun 01 2017	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	56.61	376	21,285	55,470	55.8 K to 55.5 K (-0.67 %)
May 22 2017	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	57.47	414	23,793	55,846	56.3 K to 55.8 K (-0.74 %)
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	A	88.80	28,000	2,486,400	28,000
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Grant	A	0.00	4,000	0	55,887	51.9 K to 55.9 K (+7.71 %)
Dec 23 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	0.82	6,500	5,298	56,163
Dec 23 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	0.81	6,500	5,265	51,887	45.4 K to 51.9 K (+14.32 %)
Nov 10 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	0.82	24,000	19,560	62,663
Nov 10 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	74.34	700	52,038	45,387	46.1 K to 45.4 K (-1.52 %)
Nov 10 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	73.65	2,600	191,490	46,087	48.7 K to 46.1 K (-5.34 %)
Nov 10 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	72.81	3,205	233,356	48,687	51.9 K to 48.7 K (-6.18 %)
Nov 10 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	71.68	3,895	279,194	51,892	55.8 K to 51.9 K (-6.98 %)
Nov 10 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	70.06	13,600	952,816	55,787	69.4 K to 55.8 K (-19.60 %)
Nov 10 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	0.82	24,000	19,560	69,387	45.4 K to 69.4 K (+52.88 %)
Oct 21 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Option Exercise	M	0.82	12,000	9,780	86,663
Oct 21 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	61.71	6,932	427,774	45,387	52.3 K to 45.4 K (-13.25 %)
Oct 21 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	60.98	5,068	309,047	52,319	57.4 K to 52.3 K (-8.83 %)
Oct 21 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Buy	M	0.82	12,000	9,780	57,387	45.4 K to 57.4 K (+26.44 %)
Jun 03 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Option Exercise	A	70.57	24,000	1,693,680	24,000
Jun 03 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Grant	A	0.00	4,000	0	45,387	41.4 K to 45.4 K (+9.66 %)
May 24 2016	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Payment of Exercise	F	64.01	414	26,500	41,387	41.8 K to 41.4 K (-0.99 %)
Dec 14 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Option Exercise	M	0.82	12,000	9,780	98,663
Dec 14 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	101.03	5,277	533,135	41,801	47.1 K to 41.8 K (-11.21 %)
Dec 14 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	102.16	6,723	686,822	47,078	53.8 K to 47.1 K (-12.50 %)
Dec 14 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Buy	M	0.82	12,000	9,780	53,801	41.8 K to 53.8 K (+28.71 %)
Jul 22 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	130.99	488	63,923	41,801	42.3 K to 41.8 K (-1.15 %)
Jul 22 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	131.56	1,412	185,763	42,289	43.7 K to 42.3 K (-3.23 %)
Jul 22 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	132.47	1,954	258,846	43,701	45.7 K to 43.7 K (-4.28 %)
Jul 22 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	130.99	488	63,923	41,801	42.3 K to 41.8 K (-1.15 %)
Jul 22 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	131.56	1,412	185,763	42,289	43.7 K to 42.3 K (-3.23 %)
Jul 22 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	132.47	1,954	258,846	43,701	45.7 K to 43.7 K (-4.28 %)
Jun 19 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	96.35	1,349	129,976	45,655	47 K to 45.7 K (-2.87 %)
Jun 19 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	95.95	2,651	254,363	47,004	49.7 K to 47 K (-5.34 %)
May 27 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Option Exercise	A	84.89	26,300	2,232,607	26,300
May 27 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Grant	A	0.00	4,400	0	49,655	45.3 K to 49.7 K (+9.72 %)
May 20 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	79.43	4,000	317,720	45,255	49.3 K to 45.3 K (-8.12 %)
May 05 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Option Exercise	M	0.82	1,000	815	110,663
May 05 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Buy	M	0.82	1,000	815	49,255	48.3 K to 49.3 K (+2.07 %)
Apr 22 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	62.59	3,000	187,770	48,255	51.3 K to 48.3 K (-5.85 %)
Apr 22 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	61.14	1,000	61,140	51,255	52.3 K to 51.3 K (-1.91 %)
Mar 20 2015	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Senior Vice P ...	Sell	S	61.45	4,000	245,800	52,255	56.3 K to 52.3 K (-7.11 %)

Page: 1